SHJ
GSK icon

Sharkey, Howes & Javer’s GSK GSK Stock Holding History

Sharkey, Howes & Javer’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-640
Closed -$32K – 256
2015
Q3 		$32K Hold
640
– – 0.02% 134
2015
Q2 		$33K Hold
640
– – 0.02% 115
2015
Q1 		$37K Buy
+640
New +$36.7K 0.02% 122

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sharkey, Howes & Javer's GSK Position: Q4 2015 in Review

Sharkey, Howes & Javer sold out of GSK (GSK) in Q4 2015, closing a stake of 640 shares — an estimated $32K sold.

Sharkey, Howes & Javer first reported a position in GSK in Q1 2015 and held it in 3 quarters. The position peaked at $37K in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Sharkey, Howes & Javer reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Sharkey, Howes & Javer sold 640 GSK shares in Q4 2015, an estimated $32K.
  • Sharkey, Howes & Javer first reported a position in GSK in Q1 2015 and held it in 3 quarters.
  • Sharkey, Howes & Javer's GSK position peaked at $37K in Q1 2015.
  • 719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Sharkey, Howes & Javer's 13F filing for Q4 2015, filed 8 Feb 2016.